for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Business

GSK buys Tesaro for $5.1 bln

Posted

UK's GlaxoSmithKline is buying U.S. cancer specialist Tesaro for $5.1 billion in a bid to rebuild the group's pharmaceuticals business. Fred Katayama reports.

Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up